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Similarities Between Corticosteroids
M. Einhorn
Abstract
Corticosteroids are a class of potent drugs with important physiological effects on the body. Regular use is linked with
common and serious side effects. This paper uses studies to analyze the similarities between various corticosteroids. All
drugs in this class are molecules that contain the same steroid backbone and are therefore associated with the same
cellular receptor. This results in a comparable mechanism and parallel overall effect in the body. Side effects of corticosteroids are analogous as well. Using the knowledge of physiological changes in the body due to corticosteroids will allow healthcare providers to determine the most effective corticosteroid least likely to cause adverse effects, and treat
and monitor the patient accordingly.

by typing corticosteroid along with other associated keywords, such as inflammation, into databases, such as
Corticosteroids are a class of commonly prescribed
Ebsco, Medline, ProQuest, and other similar databases.
drugs containing a backbone of four fused cycloalkanes.
These drugs are prescribed to treat a wide variety of ail- Similarity in Structure
ments including: autoimmune disorders, arthritis, asthma,
Steroids are molecules with a backbone consisting
dermatitis, cancer treatment, pain management and othof three bonded cyclohexane rings fused with a cyclopeners. Corticosteroid drug therapy is currently used in the
tane. The backbone can vary in oxidation state as well as in
treatment of over 175 diseases. Additionally, these drugs
functional groups, producing numerous different steroid
are commonly used by patients, as seen by the fact that
molecules. The body produces cholesterol and steroid horAdvair diskus, a corticosteroid inhaler, was sixth in retail
mones as part of normal function, most importantly: aldossales during the year 2013. The drug can be administered
terone, and the sex hormones. Synthetic steroids can be
and absorbed by the body in a variety of different forms:
introduced into the body.
topically applied creams, inhaled sprays, injected systemiCorticosteroids are a class of drugs similar to the
cally, drops for the eyes or ears, and orally. What are the
common physiological effects of the different corticoster- hormone cortisol, and they contain this steroid backbone.
oids? The medications in this class share a common molec- Different corticosteroids vary somewhat in shape due to
ular backbone and cause analogous effects on a cellular the differing functional groups and oxidation state. Though
level. Much research has been done trying to determine an all steroid molecules are quite similar in structure, slight
exact mechanism of steroidal function. Mechanisms have changes between each molecule’s backbone results in
been proposed, but as of today, they are hypotheses that differing affinity between the molecule and the correexplain some, but not all, effects. Though corticosteroid sponding glucocorticoid receptor . Structural changes also
drugs are used for seemingly disparate pathologies, there affect the bioavailability of a corticosteroid. Inhaled cortiare many similarities in physiological effects of corticoster- costeroids with a hydroxyl group on carbon 21 have been
shown both in vitro and in vivo to undergo esterification
oids, both medicinal as well as detrimental.
inside lung cells and therefore take a longer period of time
Methods
to eliminate from the body (Kelly, 2009).

Introduction

The similarities between the corticosteroid class of drugs,
Mechanism of Action
as well as the differences between specific corticosteroids,
The physiological effects of corticosteroids are well
were analyzed using original studies and critiques obtained
M. Einhorn is pursuing a B.S. in Biology.
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documented, and medical practitioners administer these
drugs because the effects are beneficial to the patients.
Corticosteroids are sometimes referred to as a “miracle
drug” because of the diverse pathologies that are alleviated or managed by these drugs. The precise mechanism of
action, nevertheless, is as of yet unknown. Much research
has been done to discover this mechanism, and varying
hypotheses have been suggested. There is a strong possibility that corticosteroids have numerous effects on a cellular level, resulting in what seems to be several valid mechanisms.

ments fluctuates depending on the strength of the corticosteroid.
In a double blind study testing the bioavailability of
different corticosteroids, desoximetasone 0.25%, clobetasol-17-propionate .05%, hydrocortisone 1.0%, and betamethasone dipropionate .064% were applied on the volar
forearm of 30 healthy volunteers. After six hours, skin color
changes were noted. The degree of skin blanching is associated with the efficacy of the corticosteroid. Though the
corticosteroid concentration in each cream was different,
the vasoconstrictive effect of the corticosteroid, as seen by
blanching of the skin was quite similar between three of
the four corticosteroids tested. Hydrocortisone caused
milder skin blanching and in fewer individuals, but is known
to be a weak corticosteroid so the results were not atypical
(Borelli et al., 2008). The clinical observation that three of
the four creams caused similar blanching despite differing
concentrations, clearly demonstrated that corticosteroids
differ in potency.

Corticosteroids function by diffusing into a cell and
binding to glucocorticoid receptors in the cytoplasm
(Barnes, 2005). The receptor corticosteroid complex stimulates changes in the cell by influencing transcription. Research testing cardiovascular effects of the corticosteroid
dexamethasone, found that treatment of cells with dexamethasone and the glucocorticoid antagonist mifepristone
(RU 486) blocked the known effects of the corticosteroid
(Hafezi-Moghdam et al., 2002). When cells are treated with
mifepristone, the glucocorticoid receptor is inactivated.
When the cell with the inactivated receptor is treated with
corticosteroid, no corticosteroid effect takes place. This
demonstrated that a corticosteroid must bind to the receptor for an effect to occur in the cell.

Research has shown that each corticosteroid has a
different binding affinity to the glucocorticoid receptor because of structural differences (Kelly, 2009). Clinical trials
show that the change in binding affinity from one corticosteroid to another is associated with the potency of the
corticosteroid (Kelly, 2009). This correlation that greater
the affinity of the corticosteroid to the receptor the more
powerful its effects, bolsters the theory that corticosteroids need to bind to the glucocorticoid receptor to have
physiological effects. The corticosteroid receptor complex
causes numerous changes in the cell, both in the short
term as well as long term.

This theory was replicated in a study showing that
dexamethasone inhibits vasculogenesis in a tumor through
suppressing vascular endothelial growth factor A. Treatment of steroid along with mifepristone prevented this
suppressive effect (Greenberger et al., 2010). A limit of the
conclusion, however, is that both studies were done using
the same corticosteroid dexamethasone, and therefore,
After binding to the corticosteroid, the activated
does not prove that other corticosteroids need to bind to
glucocorticoid receptor complex is transported from the
the glucocorticoid receptor to have an effect.
cytoplasm into the nucleus and binds to the promoter of
Further proof of this theory lies in the clinically specific genes containing the glucocorticoid response eleseen observation that different topical corticosteroids have ments. This induces transcription of glucocorticoid redifferent potencies. Corticosteroids are therefore separat- sponse elements mRNA (Barnes, 2005). In endothelial cells,
ed into classes. In the United States, corticosteroids are dexamethasone induced promoter activity for the glucodivided in classes from one, the extremely potent, to sev- corticoid response elements and caused transcription of
en, the least potent. In Europe, classes are numbered these genes beginning four hours after treatment of cells.
differently with class one, the mild corticosteroids, to class Actinomycin D, which inhibits transcription, and 5, 6four, the strongest of the corticosteroids. Percentage of dichlorobenzimidazole riboside, which inhibits RNA polyactive ingredient in corticosteroid creams, lotions, or oint- merase, given in conjunction with the corticosteroid
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blocked the promoter activity (Hafezi-Moghdam et al.,
2002). These results indicate the influence of corticosteroids on transcription, which will subsequently affect proteins produced by the cell.

alloproteinase 1, interleukin-6, and monocyte chemoattractant protein 1. The latter two molecules are both
involved with the immune system (Greenberger et al.,
2010). Inhibition of metalloproteinase is also seen in corticosteroid treatment of arthritic diseases (Fubini et al.,
2001). Steroidal medications induce changes in gene expression. The expressed genes, as well as the repressed
genes, have physiological effects on the cell, which are
attributed to the corticosteroid.

Some of the genes contained within the glucocorticoid response elements code for proteins with antiinflammatory effects, such as interleukin 10. Leucine zipper protein and I kappa beta alpha (IkBα) are proteins synthesized in a cell exposed to corticosteroid. They suppress
an important proinflammatory transcription factor called
nuclear factor kappa B (Barnes, 2006). Some genes are
indirectly inhibited by corticosteroids through the suppression of nuclear factor kappa B (Maneechotesuwan et al.,
2009). There are also genes directly inhibited by corticosteroids, and these genes are considered to be negative
glucocorticoid response elements. Examples of these directly suppressed genes include genes that regulate osteocalcin and keratin (Barnes, 2006). The suppression of
these proteins results in common side effects of corticosteroids, such as epidermal, and to a lesser extent, dermal
thinning and increased risk of fractures.

Numerous studies demonstrate that corticosteroids affect transcription, but this does not explain all of the
physiological effects of corticosteroids. Corticosteroids
inhibit cytokine production in T helper 2 cells, specifically
interleukin 4, 5, and 13. The genes coding these interleukins are not fully regulated by nuclear factor kappa B and
are not known to be part of the glucocorticoid response
element (Maneechotesuwan et al., 2009). Additionally,
effects of dexamethasone were seen in cells after only ten
minutes , quite a short time for the transcription of glucocorticoid response element genes and translation of corresponding proteins. Furthermore, although the inhibitor of
transcription actinomycin D blocked the promoter of the
glucocorticoid response elements, overall the molecule did
not inhibit the physiological changes of a cell exposed to
dexamethasone (Hafezi-Moghdam et al., 2002). Based on
these observations, the theory that corticosteroids binding
to a receptor cause a cell to express certain genes and repress others is insufficient.

Corticosteroids inhibit proteins that have deleterious effects on specific pathologies. As a result corticosteroid therapies are beneficial for these diseases. A study
seeking to explain the function of corticosteroid therapy in
the treatment of infantile hemangioma found that the medicinal property was due to a negative glucocorticoid response elements and a decrease in amount of a corresponding protein. Corticosteroids suppressed the expression of vascular endothelial growth factor A mRNA and
protein in hemangioma stem cells in a dose dependent
manner, suggesting that corticosteroids may slow the
growth of cancer cells. . Untreated infantile hemangioma
cells express larger quantities of vascular growth factor
than normal endothelial cells, but use of corticosteroids
inhibited growth factor mRNA and protein. This effect was
replicated using different corticosteroids including dexamethasone, prednisone, prednisolone, methylprednisolone, and hydrocortisone (Greenberger et al., 2010) leading to a conclusion that this effect is common to all corticosteroids. Other proangiogenic factors were suppressed in
the hemangioma stem cells, in addition to vascular endothelial growth factor A. These factors included matrix met-

T cells exposed to anti CD3 antibodies and anti CD
28 antibodies cause GATA-3, a transcription factor, to be
imported into the nucleus and stimulate the expression of
interleukin 4 and 5. T lymphocytes that were exposed to
the corticosteroid, known as fluticasone propionate, were
found to have inhibited GATA-3, which affected interleukin
gene expression. Interleukin 4 expression, which is regulated by GATA-3, was inhibited, and GATA-3 did not bind to
the promoter of interleukin 5. Research on this phenomena found that GATA-3 uses importin alpha for protein to
enter the nuclear membrane. Activated glucocorticoid receptors use importin alpha for nuclear translocation as
well, leading to competition between GATA-3 and the glucocorticoid receptor for importin alpha. This decreased
quantity of importin alpha available to GATA-3 results in
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less nuclear translocation, less transcription, and less trans- by cells exposed to corticosteroids and the physiological
lation of interleukins 4,5, and 13 (Maneechotesuwan et al., effects these proteins have on the cell.
2009).
Corticosteroids were found to have nontranscriptional effects as well. Treating endothelial cells
with dexamethasone stimulated endothelial nitric oxide
synthase, an enzyme that has physiological effects on the
cells. Activating the enzyme begins with the corticosteroid
binding to the glucocorticoid receptor. The complex stimulates protein kinase B (also known as Akt) either directly or
indirectly through the phosphoinositide 3-kinase/Akt pathway. Protein kinase B phosphorylates endothelial nitric
oxide synthase thereby activating this enzyme (HafeziMoghdam et al., 2002). Researchers carried out this experiment with only one corticosteroid, dexamethasone, and
the cells were evaluated for the function of only one enzyme. This raises an important question whether a corresponding mechanism applies to other corticosteroids and
the phosphorylation and activation of other enzymes.

Therapeutic Usage of Corticosteroids

The properties listed above are what cause corticosteroids to have a therapeutic influence on a wide variety of diseases. One of the most common uses of corticosteroids is in the treatment and management of asthma
(Eurich et. al, 2013) and other diseases characterized by an
obstructed airway (Sibila et al, 2013). Corticosteroids are
used to treat inflammation in other areas of the body as
well. Therefore, corticosteroid drug therapy is commonly
used to treat inflammatory skin disease,s such as eczema
and psoriasis. Injections of corticosteroids are used in the
controlling of inflammation and the suppression of matrix
metalloproteinase activity in arthritic diseases (Fubini et
al.,2001). Corticosteroids are beneficial for autoimmune
disorders because of the immunosuppressive effect. Some
pathologies, such as allergies, are aided by both the antiGeneral Effects of Corticosteroid Drugs
inflammatory and immunosuppressive effects of corticoBased on proteins produced or inhibited, as well as steroids.
the enzymes activated in a cell exposed to corticosteroids,
The proteins produced in cells exposed to corticothese drugs have predictable physiological effects. One of steroids are beneficial to some diseases. Cardiovascular
the most important effects of corticosteroid drugs is the disease can be treated using corticosteroids, though a high
suppression of inflammation. This effect is so significant dose is needed to achieve results (Hafezi-Moghdam et al.,
that other drugs that also have anti-inflammatory proper- 2002). Dexamethasone increased the activity of the enties are separated into a class titled nonsteroidal anti- zyme endothelial nitric oxide synthase (eNOS) and the proinflammatory drugs (NSAIDs). Healthcare practitioners duction of nitric oxide. This radical protects muscle mitherefore often prescribe corticosteroids in the treatment crovessels in mice after ischemia. Under normal condiof pathologies involving an inflammatory reaction. Inflam- tions, leukocytes are present in the blood and do not admation is associated with the immune system, and cortico- here to venule walls. Following ischemia and reperfusion,
steroids influence cytokine production, increasing some leukocytes’ velocity in the bloodstream decreases and they
cytokines while decreasing others, resulting in an immuno- begin to stick to the venule walls. Mice given dexamesuppressant effect. Repressing the immune system is ben- thasone, directly following the ischemia and reperfusion,
eficial for the treatment of pathologies caused by an over- did not have the decrease in leukocyte velocity and the
active immune system, but detrimental to a patient on increase in adhesion normally seen after ischemia and
long-term corticosteroid therapy. Immune system suppres- reperfusion (Hafezi-Moghdam et al., 2002). This effect was
sion increases patient susceptibility to infections, which studied in the cremaster muscle, but corticosteroids were
can become quite serious. This effect is especially deleteri- found to have beneficial effects on myocardium as well.
ous to patients with compromised immune system due to Dexamethasone treated mice were found to have myocarother medical issues. Corticosteroids affect mRNA tran- dial infarctions affecting a smaller percentage of their rescription and proteins produced in the cell. Researchers gion at risk for infarction, while mice in the control group
are studying the effects of proteins produced or repressed
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had a larger percentage of their region at risk affected by a
myocardial infarction. Other studies have demonstrated
that corticosteroids given to cardiovascular patients improved short-term survival following a myocardial infarction. In the experiments using mice, only very high doses
caused physiological effects, and an established clinical
dose offered no cardiovascular protection (HafeziMoghdam et al., 2002).

infantile hemangioma. They suppress vascular endothelial
growth factor A, thereby inhibiting tumor vasculogenesis
and limiting tumor growth (Greenberger et al., 2010). Additional research is needed to determine whether this
effect extends to other forms of cancer and can be used
accordingly, as a part of treatment. Furthermore, the safety of corticosteroid therapy in cancer patients must be
evaluated as well.

Corticosteroids are effective in reducing pain, as
evidenced by a study comparing the effectiveness of intravenous hydrocortisone plus conventional treatment versus
a placebo and conventional methods at reducing a severe
postdural puncture headache. The results clearly showed
the effectiveness of corticosteroids at reducing intense
pain. Dural puncture is thought to cause a headache by
causing cerebral spinal fluid leakage and a lessening of the
fluid cushioning around the brain. The mechanism for the
resolution of the headache is unknown, but possibilities
include the anti-inflammatory properties of corticosteroids
at the puncture site, the suppression of interleukins and
prostaglandins, and causing the reabsorption of cerebrospinal fluid (Alam et al., 2012). Similarly, corticosteroids, in
addition to antibiotics, relieved the pain and symptoms of
patients suffering strong discomfort from pharyngitis sooner than than antibiotics and a placebo did (Bergeson et. al.,
2013).

Side Effects Common to Corticosteroids
The change in proteins produced by a cell exposed
to corticosteroids has numerous effects on the cell, both
positive and negative. Side effects of a corticosteroid depend on the binding affinity, which is the potency of the
given corticosteroid; the length of time for which it is taken; and the method of introduction in the body. Side
effects of topically applied corticosteroids generally affect
the location of application.
Skin atrophy is a common effect of corticosteroids
(Cobman and Wezel, 2006). In a double blind study, twenty
healthy volunteers applied four different topical corticosteroids with differing potencies to their volar arm for four
weeks. Researchers quantified skin atrophy, using optical
coherence tomography to measure epidermal thickness,
and using high frequency ultrasound to measure dermal
thickness. Additionally, they used a profilometer, an instrument that measures the profile of a given surface, to quantify epidermal roughness. All of the volunteers experienced
epidermal thinning, demonstrating the frequency of this
side effect. The epidermis thickened considerably after
treatment was completed, but three weeks after finishing
treatment, the epidermis was still measurably thinner than
it had been before treatment. The subjects were followed
for only three weeks following steroid use, so the length of
time for which this effect persisted and the time needed
for the epidermis to return to its original thickness was not
determined in the study. The dermis of volunteers thinned
as well. The dermal thinning, however, was less than that
of the epidermal thinning. Additionally, three weeks posttreatment the dermis had almost returned to its original
thickness. Using the profilometer, areas of corticosteroid
use had a decreased roughness. The effect of the corticosteroid on the skin corresponded with its known potency;
the more potent corticosteroids caused more significant

Topical corticosteroids have the benefit of maintaining a localized concentration of corticosteroids. Patients with bullous pemphigoid, a potentially fatal autoimmune disease of the skin, were divided into one group receiving treatment of 40 grams of the topical corticosteroid
0.5% clobetasol propionate twice daily, and the other
group was treated with one milligram per kilogram of oral
prednisone. The topical corticosteroid was found to be
more effective at controlling the disease and caused a lower incidence of side effects than the oral corticosteroid
(Joly et al., 2002). Similarly, topical steroids were found to
be effective at reducing inflammation and ear discharge in
otitis media. Clinicians commonly prescribe ear drops, containing a combination of an antibiotic, such as Augmentin®,
and a corticosteroid, to treat otitis media with discharge
(Florea et al., 2006).
Corticosteroids are used in oncology treatment of
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thinning. Hydrocortisone, a mild corticosteroid, did not cleosis did not worsen the infection (Bergeson et al., 2013).
cause significant atrophy.
These studies did not follow up with the patients to see if
any long-term effect or non-immediate reaction to the corIt is evident from this study that in many cases, the
ticosteroid occurred. Additionally, it is possible that cortiskin, particularly the epidermis, is affected by corticostercosteroids cause subtle effects that are not detected by
oid use (Cobman and Wezel, 2006). This effect is likely belaboratory means currently available.
cause corticosteroids directly inhibit genes coding the proA low to medium dose of inhaled corticosteroid is
tein keratin; these genes are part of the negative GRE.
Healthcare providers should treat a patient using the least not likely to cause adverse effects (Kelly, 2009). As an impotent corticosteroid found to be effective and should munosuppressant, regular corticosteroid use may negamonitor skin changes in the patient (Cobman and Wezel, tively impact the immune system’s ability to fight infection.
2006). Similar results were obtained in a study testing the Eighty nine patients, with a diagnosis of communityeffects of corticosteroids on different skin phototypes. An acquired pneumonia and had previously taken inhaled coradditional side effect of corticosteroids was seen in the ticosteroids, were compared with a control group of 575
patients, with the same diagnosis who had not taken any
study: changed skin pigmentation (Shlivko et al., 2013).
inhaled corticosteroids. Inhaled corticosteroids are used in
The method used to introduce corticosteroids into the
the control of disorders involving lung inflammation, such
body influences the side effects experienced by the paas asthma and COPD. The corticosteroid inhaler is generaltient. The effects of topical corticosteroids are concentratly used daily or on a regular basis. The patients, who had
ed and limited to the location of application. Therefore,
previously used inhaled corticosteroids, were more likely
topical corticosteroids may be more effective for treatto have an illness caused by an antibacterial resistant miment of the skin and are known to have a lower toxicity as
crobe and presented a more critical case of pneumonia
compared to oral corticosteroids (Joly et al., 2002).
upon admission. Clinicians measure pneumonia by using
Based on numerous studies, adverse effects of oral the Pneumonia Severity Index and Curb-65 scores, which
corticosteroids are not detected at low and infrequent dos- measures the likelihood of the pneumonia patient to die
es. Patients treated with oral corticosteroids were evaluat- from their disease within 30 days (Sibila et al., 2013). Simied for risk of bone fractures. Those on medium to high larly, a study of 6874 patients, who had communitydoses of prednisone or prednisolone were found to have acquired pneumonia, found that inhaled corticosteroid use
increased risk of fracture. Significantly, the fracture risk in high-risk patients increased the risk of a repeat incident
remained elevated for up to a year after the last dose, indi- of pneumonia by ninety percent (Eurich et al., 2013).
cating that effects of corticosteroids linger even after dis- Healthcare providers should relay this risk to asthmatic
continuing drug therapy . Budesonide has a low systemic patients and instruct the patient, or the patient’s caregiver,
availability, as it is designed for release in the intestine. to seek medical care as soon as they feel symptoms of
Due to the low systemic concentration, budesonide was pneumonia. Earlier diagnosis will lead to treatment and a
not associated with increased risk of fracture. Methylpred- better prognosis.
nisolone is generally not used regularly, and as a result, did
Treatment of arthritis using corticosteroids has
not cause an increased risk of fractures. Likewise, low dosbeen proven effective. There are negative effects, howeves of corticosteroids and doses taken intermittently were
er, and a healthcare provider should perform a benefit vernot associated with increased risk (Vestergaard et al.,
sus risk assessment and treat the patient accordingly. Cor2008). Similarly, short-term use of corticosteroids in
ticosteroid injections into joints negatively affected chontreating the intense pain of a postdural headache did not
drocytes, in addition to the cartilage damaged by the arcause short-term negative effects (Alam et al., 2012). Addithritis. A single dose of methylprednisolone succinate suptionally, in the study using corticosteroids to treat severe
pressed the expression of type 2 procollagen mRNA and
sore throat, the corticosteroids did not exacerbate illness.
decreased the relative percentage of the fibronectin form
Likewise, the use of corticosteroids in croup and mononu43
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unique to cartilage. Researchers found that injecting the
recommended dose of methylprednisolone acetate into
synovial fluid resulted in a high corticosteroid concentration, that was maintained for a longer period of time, because the half-life of corticosteroid in synovial fluid is
found to be 10.3 hours (Fubini et al., 2001).

Alam M, Rahman M, Ershad R. Role of very short-term intravenous
hydrocortisone in reducing postdural puncture headache. Journal Of
Anaesthesiology, Clinical Pharmacology [serial online]. April 2012;28
(2):190-193. Available from: Medline, Ipswich, MA. Accessed January 8,
2014.
Barnes P. How corticosteroids control inflammation: Quintiles Prize
Lecture 2005. British Journal Of Pharmacology [serial online]. June
2006;148(3):245-254. Available from: Medline, Ipswich, MA. Accessed
January 8, 2014.

Conclusion
Corticosteroids are a class of drugs with similarities
in structure, and they have immunosuppressant and antiinflammatory properties with comparable mechanisms.
Gene expression is affected by corticosteroids, with genes
coding the glucocorticoid response elements expressed
more than normal, while other genes coding interleukins
are inhibited. Various corticosteroids are used in a wide
variety of disparate pathologies, because of their
immunosuppressant and anti-inflammatory properties.
These properties are responsible for the side effects of corticosteroids, including a decreased immune function and
changes in cells exposed to high concentrations of
corticosteroids. Differences in corticosteroid structure influence bioavailability and affinity to glucocorticoid receptor; both of which are directly related to potency.
Additionally, the method of introduction of corticosteroid
into the body, as well as the place of introduction, are major determinants of corticosteroid effects.
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Overall, corticosteroids are an important method
of treatment for illnesses involving an overactive immune
system and/or inflammation. However, their use should be
limited, as much as possible, due to their side effects. Before prescribing corticosteroids, physicians and other
healthcare providers should evaluate the patient’s overall
immune function and assess the need for corticosteroid
therapy. Healthcare providers should experiment with the
patient to determine the least potent, lowest dose of corticosteroid found to be effective, particularly in patients requiring long-term use. Patients or the primary caregiver, in
the case of children or the elderly, need to be informed of
the possible side effects such as increased risk of infection
and thinning of the skin. Awareness of corticosteroid risk,
along with monitoring by medical professionals, will likely
diminish many of the adverse side effects accompanying
corticosteroid
use.
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